Yahoo

Correo

U.S. markets open in 5 hours 2 minutes

F S&P 500
5,532.25
+10.75(+0.19%)
F Dow Jones
39,511.00
+42.00(+0.11%)
F Nasdaq
19,971.00
+43.75(+0.22%)
E-mini Russell 2000 Index Futur
2,073.30
+8.30(+0.40%)
Petróleo
82.26
+0.72(+0.88%)
Oro
2,333.40
-6.20(-0.27%)

HilleVax, Inc. (HLVX)

NasdaqGS - NasdaqGS Precio en tiempo real. Moneda en USD.

Añadir a la lista de seguimiento

14.46

+1.09

(+8.15%)

Al cierre: 04:00PM EDT

14.46

0.00

(0.00%)

Fuera de horario:

04:20PM EDT

Accionistas principales

Nómina de miembros de la gerencia

Transacciones de miembros de la gerencia

Moneda en USD

Compras de miembros de la gerencia en los últimos 6 meses	Acciones	Trans
Compras	4,850,144	9
Ventas	130,870	11
Acciones netas compradas (vendidas)	4,719,274	20
Acciones totales pertenecientes a miembros de la gerencia	8.14M	N/D
Acciones netas compradas (vendidas) en %	138.10%	N/D

Compras institucionales netas del trimestre anterior al último	Acciones
Acciones netas compradas (vendidas)	N/D
Cambio en acciones institucionales propias en %	N/D

Información confidencial de transacciones reportada (últimos dos años)

Miembro de la gerencia	Transacción	Tipo	Valor	Fecha	Acciones
KOHLI ADITYA PH.D. Director	Sale at price 14.21 - 15.45 per share.	Directo	266,291	22 may 2024	18,000
KOHLI ADITYA PH.D. Director	Sale at price 14.01 - 14.15 per share.	Directo	96,770	03 may 2024	6,898
KOHLI ADITYA PH.D. Director	Sale at price 14.44 - 14.93 per share.	Directo	264,467	05 abr 2024	18,000
FRAZIER LIFE SCIENCES VIII, L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.50 per share.	Indirecto	128,325	04 abr 2024	8,850
FRAZIER LIFE SCIENCES X, L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.50 per share.	Indirecto	128,325	04 abr 2024	8,850
MCLOUGHLIN SEAN Chief Operating Officer	Purchase at price 16.98 per share.	Directo	21,225	28 mar 2024	1,250
KOHLI ADITYA PH.D. Director	Sale at price 17.42 - 17.66 per share.	Directo	315,008	20 mar 2024	18,000
KOHLI ADITYA PH.D. Director	Sale at price 18.37 - 18.95 per share.	Directo	335,872	08 mar 2024	18,000
KOHLI ADITYA PH.D. Director	Sale at price 14.88 - 15.05 per share.	Directo	269,078	22 feb 2024	18,000
KOHLI ADITYA PH.D. Director	Sale at price 15.32 per share.	Directo	91,921	12 feb 2024	6,000
HERSHBERG ROBERT M Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	08 feb 2024	174,202
HERSHBERG ROBERT M Chief Executive Officer	Sale at price 14.93 per share.	Directo	173,161	08 feb 2024	11,597
MALTBIE SHANE Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	08 feb 2024	47,522
MALTBIE SHANE Chief Financial Officer	Sale at price 14.93 per share.	Directo	53,395	08 feb 2024	3,576
KOHLI ADITYA PH.D. Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	08 feb 2024	54,898
KOHLI ADITYA PH.D. Director	Sale at price 14.93 per share.	Directo	132,383	08 feb 2024	8,866
BORKOWSKI ASTRID Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	08 feb 2024	53,632
BORKOWSKI ASTRID Officer	Sale at price 14.93 per share.	Directo	58,726	08 feb 2024	3,933
BORKOWSKI ASTRID Officer	Sale at price 15.50 per share.	Directo	155,000	15 dic 2023	10,000
BORKOWSKI ASTRID Officer	Sale at price 14.20 - 14.50 per share.	Directo	287,000	04 dic 2023	20,000
BORKOWSKI ASTRID Officer	Sale at price 14.00 per share.	Directo	140,000	17 nov 2023	10,000
BORKOWSKI ASTRID Officer	Sale at price 13.00 per share.	Directo	65,000	08 nov 2023	5,000
HERSHBERG ROBERT M Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	01 feb 2023	187,966
MALTBIE SHANE Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	01 feb 2023	43,333
KOHLI ADITYA PH.D. Chief Operating Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	01 feb 2023	85,466
BORKOWSKI ASTRID Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	01 feb 2023	51,333
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.00 per share.	Indirecto	588	30 nov 2022	5,883,500
FRAZIER LIFE SCIENCES VIII, L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.00 per share.	Indirecto	30,000,002	03 may 2022	1,764,706
FRAZIER LIFE SCIENCES VIII, L.P. Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 13.60 per share.	Indirecto	37,212,782	03 may 2022	2,736,234
FRAZIER LIFE SCIENCES X, L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.00 per share.	Indirecto	30,000,002	03 may 2022	1,764,706
FRAZIER LIFE SCIENCES X, L.P. Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 13.60 per share.	Indirecto	37,212,782	03 may 2022	2,736,234

F S&P 5005,532.25+10.75(+0.19%)

F Dow Jones39,511.00+42.00(+0.11%)

F Nasdaq19,971.00+43.75(+0.22%)

E-mini Russell 2000 Index Futur2,073.30+8.30(+0.40%)

Petróleo82.26+0.72(+0.88%)

Oro2,333.40-6.20(-0.27%)

HilleVax, Inc. (HLVX)

Transacciones de miembros de la gerencia

Información confidencial de transacciones reportada (últimos dos años)

F S&P 500
5,532.25
+10.75(+0.19%)

F Dow Jones
39,511.00
+42.00(+0.11%)

F Nasdaq
19,971.00
+43.75(+0.22%)

E-mini Russell 2000 Index Futur
2,073.30
+8.30(+0.40%)

Petróleo
82.26
+0.72(+0.88%)

Oro
2,333.40
-6.20(-0.27%)